BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 11756660)

  • 1. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis.
    Ino Y; Gotoh M; Sakamoto M; Tsukagoshi K; Hirohashi S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):365-70. PubMed ID: 11756660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
    Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
    Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells.
    Shimamura T; Yasuda J; Ino Y; Gotoh M; Tsuchiya A; Nakajima A; Sakamoto M; Kanai Y; Hirohashi S
    Cancer Res; 2004 Oct; 64(19):6989-95. PubMed ID: 15466191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of P2B/LAMP-1, a major protein target of a metastasis-associated oligosaccharide structure.
    Heffernan M; Yousefi S; Dennis JW
    Cancer Res; 1989 Nov; 49(21):6077-84. PubMed ID: 2676155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63.
    Imai T; Fukudome K; Takagi S; Nagira M; Furuse M; Fukuhara N; Nishimura M; Hinuma Y; Yoshie O
    J Immunol; 1992 Nov; 149(9):2879-86. PubMed ID: 1401919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
    Nam JS; Ino Y; Sakamoto M; Hirohashi S
    Clin Cancer Res; 2002 Jul; 8(7):2430-6. PubMed ID: 12114449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line.
    Supriatno ; Harada K; Kawaguchi S; Yoshida H; Sato M
    Oncol Rep; 2003; 10(3):527-32. PubMed ID: 12684618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.
    Liu N; Gao F; Han Z; Xu X; Underhill CB; Zhang L
    Cancer Res; 2001 Jul; 61(13):5207-14. PubMed ID: 11431361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin regulates the association between beta-catenin and actinin-4.
    Hayashida Y; Honda K; Idogawa M; Ino Y; Ono M; Tsuchida A; Aoki T; Hirohashi S; Yamada T
    Cancer Res; 2005 Oct; 65(19):8836-45. PubMed ID: 16204054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single amino acid substitutions in conserved extracellular domains of E-cadherin differ in their functional consequences.
    Handschuh G; Luber B; Hutzler P; Höfler H; Becker KF
    J Mol Biol; 2001 Nov; 314(3):445-54. PubMed ID: 11846558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
    Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
    Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.
    Nam JS; Kang MJ; Suchar AM; Shimamura T; Kohn EA; Michalowska AM; Jordan VC; Hirohashi S; Wakefield LM
    Cancer Res; 2006 Jul; 66(14):7176-84. PubMed ID: 16849564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of a tumor-associated antigen, beta-casein-like protein.
    Baba T; Koizumi M; Suzuki T; Yamanaka I; Yamashita S; Kudo R
    Biochem Biophys Res Commun; 2001 Jun; 284(2):340-5. PubMed ID: 11394883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
    Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
    Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Function of IL-18 in promoting metastasis of lung cancer].
    Jiang DF; Liu WL; Lu YL; Qiu ZY; He FC
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):348-52. PubMed ID: 12921563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.